
Nytt blodprov kan upptäcka aggressiv prostatacancer
Granskad av Joe CrowtherFörfattad av Ashwin BhandariUrsprungligen publicerad 16 sept 2019
Uppfyller patientens redaktionella riktlinjer
- Ladda nerLadda ner
- Dela
- Language
- Diskussion
- Ask Patient
- Ljudversion
- Lägg till i föredragna källor på Google
Enligt forskning från Queen Mary University of London har ett nytt blodprov visat sig kunna upptäcka förekomsten av aggressiv prostatacancer med hög precision.
Looking for home psa testing?
Get expert healthcare advice from the comfort of home. Complete a quick online consultation, available 24/7, with your request reviewed by a UK-registered clinician. Next day delivery available on eligible treatments.
By combining the current prostate specific antigen (PSA) test with the new test (the circulating tumour cell (CTC) test, this could help men avoid unnecessary and invasive biopsies, over-diagnosis and over-treatment.
Prostate cancer is currently detected using a blodprov that measures PSA levels. Although it provides early diagnosis, 75% of all PSA positive results ending up with negative biopsies that do not find cancer.
The study, published in the Journal of Urology, looked at the use of the CTC test in almost 100 pre-biopsy patients and over 150 newly diagnosed prostate cancer patients at St Bartholomew's Hospital in London.
The research team found that the presence of CTCs in pre-biopsy blood samples was indicative of the presence of aggressive prostate cancer, and efficiently and non-invasively predicted the later outcome of biopsy results.
When the CTC tests were used in combination with the current PSA test, it was able to predict the presence of aggressive prostate cancer in other biopsies with over 90% accuracy.
The test could also show how aggressive the cancer is. Focusing on more aggressive prostate cancer may reduce overtreatment and unnecessary biopsies for benign and non-aggressive conditions.
Lead researcher Professor Yong-Jie Lu from Queen Mary University of London said: "The current prostate cancer test often leads to unnecessary invasive biopsies and over-diagnosis and over-treatment of many men, causing significant harm to patients and a waste of valuable healthcare resources. There is clearly a need for a better selection process for patients to undergo the biopsy procedure.
"Testing for circulating tumour cells is efficient, non-invasive and potentially accurate, and we've now demonstrated its potential to improve the current standard of care. By combining the new CTC analysis with the current PSA test, we were able to detect prostate cancer with the highest level of accuracy ever seen in any biomarker test, which could spare many patients unnecessary biopsies. This could lead to a paradigm shift in the way we diagnose prostate cancer," he added.
Due to the small sample size, the findings will need to be validated by further studies. However, researchers said the CTC test could be available on the NHS in as little as three years if successful.
Sara Hiom, Cancer Research UK's director of early diagnosis, said: "It's early days, so the next steps would be to study a larger number of people."
Looking for home psa testing?
Get expert healthcare advice from the comfort of home. Complete a quick online consultation, available 24/7, with your request reviewed by a UK-registered clinician. Next day delivery available on eligible treatments.
Patientval för Manlig cancer

Cancer
Urinprov för prostatacancer kan avslöja vem som behöver akut behandling
Forskare har utvecklat ett urintest för att identifiera män som troligen behöver behandling efter att ha diagnostiserats med tidig prostatacancer.
av Ashwin Bhandari

Cancer
Vilka är tecknen på prostatacancer?
I Storbritannien är prostatacancer den vanligaste cancerformen hos män och orsakar 12 300 dödsfall per år. Beroende på hur cancercellerna växer kan du utveckla märkbara tecken på prostatacancer eller inte. För att ge dig själv bästa möjliga chans till diagnos och överlevnad är det viktigt att vara medveten om de viktigaste tecknen och även att gå på regelbundna läkarkontroller när du fyllt fyrtio.
av Lynn Stephen
Om recensenten

Joe Crowther
Artikelhistorik
Artikeln finns också på Engelska, Tyska, Spanska, Franska, Italienska, Portugisiska, Hindi, Hebreiska, Arabiska, och Svenska.
16 sept 2019 | Ursprungligen publicerad
Författad av:
Ashwin BhandariGranskad av
Joe Crowther
Dela dina tankar eller erfarenheter med andra i vår patientgemenskaper.
Anmäl dig till Patientens nyhetsbrev
Din veckovisa dos av tydliga, pålitliga hälsoråd - skrivna för att hjälpa dig känna dig informerad, självsäker och i kontroll.
Genom att prenumerera accepterar du våra Sekretesspolicy. Du kan avsluta prenumerationen när som helst. Vi säljer aldrig dina uppgifter.


